Innovent Biologics, Inc.
Innovent Biologics, Inc. scores highest on Nitro (78) and lowest on Price (4). Its PosiPenta is 48.08 out of 100, around the middle of similar companies.
On the Penta Grid this week, Innovent Biologics, Inc. is Grid #6 of 7 in the Healthcare sector in China, and Grid #34 of 58 in China.
Compared with similar companies in the Healthcare sector in China.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Innovent Biologics, Inc. | 48.08 | 4 | 58 | 78 | 58 | 43 |
| JD Health International Inc. | 48.56 | 43 | 59 | 35 | 67 | 38 |
| WuXi Biologics (Cayman) Inc. | 53.11 | 15 | 58 | 86 | 68 | 38 |
| Hansoh Pharmaceutical Group Company Limited | 47.56 | 12 | 28 | 59 | 76 | 61 |
| CSPC Pharmaceutical Group Limited | 54.87 | 46 | 13 | 81 | 85 | 49 |
| Sinopharm Group Co. Ltd. | 52.67 | 95 | 53 | 48 | 24 | 42 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 117.17 |
| P/B ratio | 6.83 |
EEarnings
| Trailing EPS | ₹9.18 |
| Forward EPS | ₹30.58 |
NNitro
| Price | 1075.91 |
| 52-week high | 1361.65 |
| 52-week low | 840.31 |
| Fall from 52-week high | 21.0% |
TTorque
| Return on equity (ROE) | 7.01% |
| Debt-to-equity | 0.11 |
AAnchor
| Beta (price swings) | 0.33 |
| Market cap | ₹1,87,624 Cr |
| Insider holding | 6.23% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Innovent Biologics, Inc.'s PosiPenta score?
Innovent Biologics, Inc.'s PosiPenta is 48.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Innovent Biologics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Innovent Biologics, Inc. is Grid #6 of 7 in the Healthcare sector in China, and Grid #34 of 58 in China.
Which PosiPenta pillar is strongest for Innovent Biologics, Inc.?
Nitro (momentum), with a score of 78 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Innovent Biologics, Inc.?
Price (valuation), with a score of 4 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.